Raul Aguilar Schall

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

Patrick Marcellin, Edward Gane, Nezam H. Afdhal et al. · The Lancet · 2012 · 1.7K citations

Hepatology, Viral Hepatitis, Liver Physiology +9

The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials

Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu et al. · Hepatology · 2019 · 361 citations

Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis

Stephen A. Harrison, Manal F. Abdelmalek, Stephen H. Caldwell et al. · Gastroenterology · 2018 · 355 citations

Hepatology, Liver Physiology, Immunology +10

Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection

Naoky Tsai, Joerg Petersen, Robert Flisiak et al. · Digestive Diseases and Sciences · 2014 · 297 citations · Full text

Prenatal and Postnatal Bisphenol A Exposure and Body Mass Index in Childhood in the CHAMACOS Cohort

Kim G. Harley, Raul Aguilar Schall, Jonathan Chevrier et al. · Environmental Health Perspectives · 2013 · 250 citations · Full text